“Our results indicated a trend of favorable response in the treatment with CBD, which has emerged as a therapeutic option for psoriasis,” researchers concluded.
Archives: News Releases
Since 1992, every Thursday and when breaking news warrants, NORML | The NORML Foundation have been issuing weekly press releases for marijuana law supporters and the media.
NORML’s News Releases archives goes back to 1996 and serves as a valuable tool to alert citizens about cannabis-related news and legislation as well as a research tool for reviewing a chronology of marijuana law reform.
“So dire is the current situation that advocates now fear that the cannabis industry in California faces an ‘existential crisis’ in the absence of meaningful tax reform.”
Thirty-nine percent of patients were able to either “completely discontinue [their use of] insomnia medications or reduce their use from nightly administration to as-needed administration.”
Investigators concluded, “[P]atients who seek treatment with medical cannabis for anxiety and depression can experience clinically significant improvements.”
Authors reported, “[P]eople with PD report that cannabis subjectively improves some PD‐related symptoms, with higher THC products conferring more frequent benefits than higher CBD products.”
The analysis found that nearly two-thirds of the products contained synthetically derived THC, despite many claiming to be ‘all natural.’
Legal states in 2021 collected an estimated 20 percent more in taxes from retail marijuana sales than from the sale of alcohol products.
“Individuals with depression, anxiety, and comorbid depression and anxiety perceive benefits from using cannabis for sleep,” investigators concluded.